insights_auto
Why is ORX up 5,76%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
0,90 SEK
arrow_upward
+5,76%(+0,049) 1D
17-ноя., 17:29:55 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
0,83 SEK
High
0,98 SEK
Low
0,83 SEK
Mkt. cap
315,79 млн
Avg. vol.
790,03 миң
Volume
719,07 миң
P/E ratio
0,07
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
0,83 SEK
High
0,98 SEK
Low
0,83 SEK
Mkt. cap
315,79 млн
Avg. vol.
790,03 миң
Volume
719,07 миң
P/E ratio
0,07
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
ChartMill
·
1 саат мурун
S&P 500 Losers: Software Stocks Lead Session Declines
TV News Check
·
18 мүнөт мурун
Dow Drops 849, Nasdaq Sinks 181, S&P 500 Falls 76
marketscreener.com
·
38 мүнөт мурун
S&P 500 Pullback Extends to Fourth Day Ahead of Nvidia's Earnings
Traders Union
·
41 мүнөт мурун
Ryan Detrick: Technology stocks outperformed S&P 500 while 75 stocks declined
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com